slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 81,871-81,900
Pages 3,986
Rows per page 30
Component
81,871-81,900 of 119,566
39
The slide includes a prominent callout box summarizing the clinical significance of the baseline data.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
40
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
41
The slide uses a simple three-circle layout to categorize the utility of NITs.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
42
The slide uses a simple Venn-like or hub-and-spoke visual, though the side circles are empty.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
43
The slide compares three groups (Placebo, AXA1125 22.6 BID, AXA1125 33.9 BID) across two time points (Week 12 and Week 24).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
44
The chart compares different trial durations (24 weeks vs 72 weeks vs 18 months) and phases (Ph2b vs Ph3).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
48
P-values are calculated using Cochran-Mantel Haenszel test vs placebo.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
51
The slide uses a dark sidebar for context and a white main area for data presentation. It includes a citation at the bottom.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
55
The table compares Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID groups.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
56
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
57
Standard corporate closing slide with branding and page number.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
59
Includes a biological pathway diagram and patient population statistics.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
62
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
01
Includes company logo, tagline, ticker symbol, and date.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Humble Origins1 hit
02
AYRO | Investor Presentation Deck | 29 slidesAYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Humble Origins1 hit
03
AYRO | Investor Presentation Deck | 29 slidesAYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Humble Origins1 hit
07
AYRO | Investor Presentation Deck | 29 slidesAYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
08
The slide cites specific market reports for its data points.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
09
The slide serves as both a product showcase and a traction metric.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Rising Success1 hit
11
The slide uses a large, high-quality photograph of industrial vehicles to set the stage for a narrative about operational or strategic change.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Rising Success1 hit
12
The slide uses a list of pain points to justify a strategic shift, effectively acting as a 'Why Now' or 'Problem Statement' for the current business model.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Rising SuccessLoop · Why Now1 hit
13
Uses a signpost metaphor to represent the pivot between 2022 and 2023.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Loop · Why Now1 hit
18
The slide uses a generic stock image overlay with tech-themed icons representing IP concepts.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
19
Mentions accelerated consideration due to inventor age.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
20
AYRO | Investor Presentation Deck | 29 slidesAYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
21
The slide provides a detailed breakdown of IP assets, specifically trademarks, for due diligence purposes.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
22
The slide uses a generic stock image of a hand pointing at an upward trend line to symbolize growth.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · The Breakthrough1 hit
27
AYRO | Investor Presentation Deck | 29 slidesAYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
28
The slide is largely empty of text, serving as a visual placeholder or transition slide.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
01
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Humble Origins1 hit